Strategic and investment advisory firm serving the global medical devices, diagnostics and biotechnology industries with particular focus on opportunities in Asia-Pacific.
Consulting services for U.S. pharmaceutical, biotechnology, medical device, and health product companies to assist in developing partnerships, joint ventures, licensing, regulatory applications, and market research in China.
Doug Berger, M.D., Ph.D. is a bilingual, American physician consultant, based in Japan, with significant experience in clinical study design and drug development.
Professionally assistance in Japan for strategic partnering and technology transfer in biortechnology, supported by Japanese-to-English translation services of relevant scientific and business documents, and by search of executives and scientists.